TNF-α and IL-6 serum levels: Neurobiological markers of alcohol consumption in alcohol-dependent patients?

Alcohol

Volumn 48, Issue 7, 2014, Pages 671-676

  Heberlein, Annemarie ^a   Käser, Marius ^a   Lichtinghagen, Ralf ^a   Rhein, Mathias ^a   Lenz, Bernd ^b   Kornhuber, Johannes ^b   Bleich, Stefan ^a   Hillemacher, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Abstinence; Alcohol dependence; Alcohol withdrawal; BDNF; IL 6; TNF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; HYDROCORTISONE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANAMNESIS; ANXIETY; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYMPTOMATOLOGY; BLOOD; CASE CONTROL STUDY; DRINKING BEHAVIOR; PSYCHOLOGY;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; HUMANS; INTERLEUKIN-6; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908040727     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2014.08.003     Document Type: Article

References (29)

1. Anton R.F., Moak D.H., Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcoholism: Clinical and Experimental Research 1995, 19:92-99.
2. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
3. Chang Y.C., Rapoport S.I., Rao J.S. Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochemical Research 2009, 34:536-541.
4. Costa M.A., Girard M., Dalmay F., Malauzat D. Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. Alcoholism: Clinical and Experimental Research 2011, 35:1966-1973.
5. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews. Neuroscience 2008, 9:46-56.
6. Freeman K., Brureau A., Vadigepalli R., Staehle M.M., Brureau M.M., Gonye G.E., et al. Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei. Journal of Neuroinflammation 2012, 9:97.
7. Fumaz C.R., Gonzalez-Garcia M., Borras X., Muñoz-Moreno J.A., Perez-Alvarez N., Mothe B., et al. Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment. Brain, Behavior, and Immunity 2012, 26:568-572.
8. Ghitza U.E., Zhai H., Wu P., Airavaara M., Shaham Y., Lu L. Role of BDNF and GDNF in drug reward and relapse: a review. Neuroscience and Biobehavioral Reviews 2010, 35:157-171.
9. Gómez C.D., Buijs R.M., Sitges M. The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1β and TNF-α expression in rat hippocampus. Journal of Neurochemistry 2014 Sep, 130(6):770-779. (Epub ahead ofprint).
10. González-Reimers E., Fernández-Rodríguez C.M., Santolaria-Fernández F., de la Vega-Prieto M.J., Martín-González C., Gómez-Rodríguez M.Á., et al. Interleukin-15 and other myokines in chronic alcoholics. Alcohol and Alcoholism 2011, 46:529-533.
11. Heberlein A., Dürsteler-MacFarland K.M., Lenz B., Frieling H., Grösch M., Bönsch D., et al. Serum levels of BDNF are associated with craving in opiate-dependent patients. Journal of Psychopharmacology 2011, 25:1480-1484.
12. Heberlein A., Muschler M., Lenz B., Frieling H., Büchl C., Gröschl M., et al. Serum levels of vascular endothelial growth factor A increase during alcohol withdrawal. Addiction Biology 2010, 15:362-364.
13. Heberlein A., Muschler M., Wilhelm J., Frieling H., Lenz B., Gröschl M., et al. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Progress in Neuro-psychopharmacology & Biological Psychiatry 2010, 34:1060-1064.
14. Huang C.J., Mari D.C., Whitehurst M., Slusher A., Wilson A., Shibata Y. Brain-derived neurotrophic factor expression exvivo in obesity. Physiology & Behavior 2014, 123:76-79.
15. Huang M.C., Chen C.H., Chen C.H., Liu S.C., Ho C.J., Shen W.W., et al. Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol and Alcoholism 2008, 43:241-245.
16. John U., Hapke U., Rumpf H.J. Anew measure of the alcohol dependence syndrome: the severity scale of alcohol dependence. European Addiction Research 2003, 9:87-93.
17. Keshavarzian A., Farhadi A., Forsyth C.B., Rangan J., Jakate S., Shaikh M., et al. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. Journal of Hepatology 2009, 50:538-547.
18. Kiecolt-Glaser J.K., Belury M.A., Andridge R., Malarkey W.B., Glaser R. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain, Behavior, and Immunity 2011, 25:1725-1734.
19. Kiecolt-Glaser J.K., Belury M.A., Andridge R., Malarkey W.B., Hwang B.S., Glaser R. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain, Behavior, and Immunity 2012, 26:988-995.
20. Kiefer F., Jahn H., Schick M., Wiedemann K. Alcohol intake, tumour necrosis factor-alpha, leptin and craving: factors of a possibly vicious circle?. Alcohol and Alcoholism 2002, 37:401-404.
21. Leclercq S., Cani P.D., Neyrinck A.M., Stärkel P., Jamar F., Mikolajczak M., et al. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects. Brain, Behavior, and Immunity 2012, 26:911-918.
22. Mayfield D., McLeod G., Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. The American Journal of Psychiatry 1974, 131:1121-1123.
23. Salome N., Tasiemski A., Dutriez I., Wigger A., Landgraf R., Viltart O. Immune challenge induces differential corticosterone and interleukin-6 responsiveness in rats bred for extremes in anxiety-related behavior. Neuroscience 2008, 151:1112-1118.
24. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993, 88:791-804.
25. Sears B.W., Volkmer D., Yong S., Himes R.D., Lauing K., Morgan M., et al. Binge alcohol exposure modulates rodent expression of biomarkers of the immunoinflammatory response to orthopaedic trauma. The Journal of Bone and Joint Surgery, American Volume 2011, 93:739-749.
26. Spielberger C.D., Gorusch R.L., Lushene R.E. Manual for the State-Trait Anxiety Inventory 1970, Consulting Psychologists Press, Inc., Mountain View, CA.
27. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). British Journal of Addiction 1989, 84:1353-1357.
28. Zgierska A., Rabago D., Zuelsdorff M., Coe C., Miller M., Fleming M. Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. Journal of Addiction Medicine 2008, 2:165-173.
29. Zunszain P.A., Hepgul N., Pariante C.M. Inflammation and depression. Current Topics in Behavioral Neurosciences 2013, 14:135-151.